Understanding the potential of liquid biopsies

The advancement of delicate CTC and cfDNA identification led to innovations that has empowered the improvement of liquid biopsies with numerous clinical applications, including-screening for nearness of disease, patient stratification and treatment determination, monitoring treatment reaction and early diagnostics.

MarketsandMarkets Virtual Conference on Liquid Biopsy will unite the pioneers from Diagnostics organization, Experts from Pharmaceutical and Bio-Pharma companies, Researchers and professors from renowned universities to address the challenges in early detection of tumor cells and the potential of liquid biopsies to screen, monitor and treatment of the diseases.

Key Highlights

Identification of circulating biomarkers for early diagnosis
Challenges and advantages to the end-users
Advancement in treatment and monitoring of cancer
Clinical and non-clinical application of liquid biopsy
Recent developments in assays for liquid biopsy
Incorporation of Artificial intelligence and machine learning in liquid biopsy

Who Should Attend?

Hospitals- Diagnostics Department, Department of clinical oncology, Pathology Labs

Designation- Oncologist, Immunologist, Hematologist, pathologist, General Practitioners, Lab managers, Lab directors, Medical directors

Universities: Designation- Professors, Researchers, Associate professors in Cancer study

Pharma/Therapeutics: Designation- CEO, COO, Senior scientist in cancer and immunology, Research scientist in cancer, Personalized medicine individuals

Why Attend?

Best networking opportunities with industrial experts from all around the world
100+ experts attending
Interactive panel discussions with pioneers of the field
Platform to showcase/exhibit innovative technologies
Expand on existing organizations and make new networks with across industry and the scholarly community